Here's Why Insulet Corporation's Investors Are Pumped

Here's Why Insulet Corporation's Investors Are Pumped

In response to the company's upbeat third-quarter results and raised guidance, shares of Insulet Corporation (NASDAQ: PODD), a medical device maker focused on diabetes and drug delivery, rose 16% as of 11:55 a.m. EDT on Friday.

Here are the key takeaways from Insulet's third quarter:

Management expects the good times to continue into the fourth quarter. The company is projecting revenue to land between $123 million and $126 million, which represents 20% at the midpoint. This range compares favorably to Wall Street's estimate of $120.9 million. 

Continue reading

Source: Fool.com